Evidence map›Paper›PMID 33835299›Full record

ReviewTopics in current chemistry (Cham)2021

Imaging, Identification and Inhibition of Microorganisms Using AIEgens.

Harini A Perera, Mingdi Yan

Abstract readReview
PubMed Publisher
In one paragraph

Review in Topics in current chemistry (Cham), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Merging antimicrobial and visible emission properties within 1,3,4-trisubstituted-1,2,3-triazolium salts.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Harini A PereraDepartment of Chemistry, University of Massachusetts Lowell, Lowell, MA, 01854, USA.
Mingdi YanDepartment of Chemistry, University of Massachusetts Lowell, Lowell, MA, 01854, USA. mingdi_yan@uml.edu.ORCID http://orcid.org/0000-0003-1121-4007

Funding

Interaction and uptake of nanoparticles by bacteria mediated by unique sugarsR15GM128164 · NIGMS · UNIVERSITY OF MASSACHUSETTS LOWELL · PI YAN, MINGDI · 2018 to 2018
$455k
NIGMS NIH HHS GM128164
6 · The paper itself

Abstract

Microorganisms, including bacteria, viruses and fungi, are ubiquitous in nature. Some are extremely beneficial to life on Earth, whereas some cause diseases and disrupt normal human physiology. Pathogenic microorganisms can also undergo mutations and develop resistance to antimicrobial agents, which complicates diagnostic and therapeutic regimens. This calls for continuing efforts to develop new strategies and tools that can provide fast, sensitive and accurate diagnosis, as well as effective treatment of ever-evolving infectious diseases. Aggregation-induced emission luminogens (AIEgens) have shown promise in imaging, identification and inhibition of various microbial species. Compared to conventional organic fluorophores, AIEgens can offer improved photostability, and have found utilities in imaging microorganisms. AIEgens have been shown to detect microbial viability and differentiate among different microbial strains. Theranostic AIEgens that integrate imaging and killing of microbes have also been developed. This review highlights examples in the literature where AIEgens have been employed as molecular probes in the imaging, discrimination and killing of bacteria, viruses and fungi.

Indexed as

Anti-Infective AgentsBacteriaFluorescent DyesFungiHumansMicrobial Sensitivity TestsMolecular StructureVirusesAnti-Infective AgentsFluorescent DyesAIEgenBacteriaFungiIdentificationImagingInhibitionViruses

Identifiers

PMID33835299

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.